Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2025-523709-13-00Phase 3Authorised
Phase 3, randomised trial in ischemic stroke comparing Sevoflurane anesthesia arm with Propofol anesthesia arm (2 arms). Primary endpoint: Final infarct volume at 72 hours. Planned start Apr 2026; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2025-523709-13-00.